Targeting Alveolar Macrophages Shows Better Treatment Response Than Deletion of Interstitial Macrophages in EGFR Mutant Lung Adenocarcinoma

Immunity, inflammation and disease - United Kingdom
doi 10.1002/iid3.293
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

Adenoviral Vectors Transduce Alveolar Macrophages in Lung Cancer Models

OncoImmunology
OncologyAllergyImmunology
2018English

Alveolar Macrophages Transport Pathogens to Lung Draining Lymph Nodes

Journal of Immunology
AllergyImmunology
2009English

MS18.03 Treatment of SCLC Transformed From EGFR Mutant Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Comparison Between Alveolar Macrophages and Langerhans' Cells in Various Lung Diseases.

Journal of the Japan Society of the Reticuloendothelial System
1990English

Intracellular Particle Dissolution in Alveolar Macrophages

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1992English

Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4

Journal of Immunology
AllergyImmunology
2018English

Correction: Broncho Alveolar Dendritic Cells and Macrophages Are Highly Similar to Their Interstitial Counterparts

PLoS ONE
Multidisciplinary
2017English

Human Alveolar Macrophages Are Deficient in PTEN

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy